The present invention is directed to a medicated oil composition comprising propolis, about 1-40% by weight, a carrier, about 30-90% by weight, an analgesic, about 0.1-10% by weight, a surfactant, about 0.25-20% by weight, and a diluent, about 5-50% by weight.

The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and other associated skin diseases or disorders.

A composition to treat atopic dermatitis having a combination of Siberian Sea Buckthorn Berry Oil at 98.0 to 99.99 of total combination percent weight; and nano diamonds at 2.0 to 0.01 of total combination percent weight respectively. In one approach, the Siberian Sea Buckthorn Berry Oil may be 99.6 to 99.8 of total combination percent weight; and the nano diamonds may be 0.02 to 0.04 of total combination percent weight respectively. In another approach, the composition may have a range of 3-8 ml of the Siberian Sea Buckthorn Berry Oil and nano diamond combination per 59 ml of a cream having 2 percent hydrocortisone. In yet another approach the composition may have 5 ml of Siberian Sea Buckthorn Berry Oil and nano diamond combination per 59 ml of a cream having 2 percent hydrocortisone.

An encapsulated bacteriophage formulation and a method for encapsulating bacteriophages and bacteriophage-related products in polymeric microcapsules is provided. Some embodiments of the method of producing the encapsulated bacteriophages involves a water-in-oil-in-water double emulsion.

A formulation of a discrete liquid patch for the treatment of cold sores or viral lesions, including a combination of the adhesive layer and an active compound/ingredient such as antiviral agents, and/or amino acids, and/or minerals/vitamins. The adhesive layer of the discrete patch is substantially free of hydrocolloid particles. The adhesive layer does not include any backing layer to maintain the compliance of the patch with a thickness ranging from 5 microns to 1,300 microns. Wherein, the discrete patch of the invention is configured to apply to a viral lesion to maintain in contact therewith for a time effective to substantially complete re-epithelialization of the lesion.

This invention relates to a packaged sterile wound dressing comprising a dressing saturated with a pain relieving composition, a method of providing pain relief due to a wound of a subject using said dressing, and a method of manufacturing the packaged sterile wound dressing.

Provided are topical analgesic spray compositions and topical analgesic spray concentrates containing menthol and camphor in high concentrations. The present disclosure also provides organoleptic compositions for use in the topical analgesic spray compositions and concentrates to provide enhanced sensory experience and long-lasting pain-relief.

The invention relates to a sprayable liquid solution for the transdermal delivery of testosterone comprising testosterone, a penetration enhancer, and a film forming excipient, and to methods of treatment using this composition.

The present invention relates to vaccination against animal pathogens using alphavirus-replicon RNA particles and oil adjuvants. To a vaccine, and a kit of parts comprising the replicon particles and the oil adjuvant. Also to methods and uses of making and using the vaccine and the components of the kit.

A cannabis-containing edible product comprises an edible substrate and a predetermined amount of a protective glaze coating on the edible substrate. The protective glaze coating comprises an edible, film-forming resin which has been applied by liquid coating techniques and contains cannabis in a predetermined concentration such that the cannabis-containing edible product contains a predetermined amount of cannabis.